Mantle Cell Lymphoma
FDA greenlights pirtobrutinib as third-line treatment for chronic lymphocytic leukemia or small lymphocytic lymphoma in adults.
Efbemalenograstim has been approved by the FDA to combat infections in adults being treated for nonmyeloid cancers.
FDA’s ODAC committee pressed for resolution on whether 2 lymphoma drugs, long on the U.S. market, actually deliver significant benefits to...
Dr. Christopher Flowers, a prominent African American oncologist with expertise in blood cancer and health disparity research, heads a key...
From the Journals
The group’s new study evaluation tool, the ESMO-MCBS:H, is aimed at helping doctors and others determine the benefit of new blood cancer therapies...
Only a small percentage of eligible patients participate in clinical trials in the first place, and very few come from racial and ethnic minority...
Few patients with cancer have access to psycho-oncologic support.
Information from germline genetic testing could affect a patient’s cancer care.